Community/Retail

Study results indicate durable immune response from bivalent booster after 3 months of follow-up.

Highest prevalence is seen among adults, outpatients, and women and can cause persistent severe anosmia or hyposmia, findings indicate.

In a panel, pharmacy technicians across the world discuss what immunizations and point-of-care testing looks like in United States, Portugal, and the United Kingdom.

In this month's generic products roundup, Cipla and Lupin have expanded with new products.

Food insecurity has previously been linked to adverse cardiovascular outcomes, but research is limited regarding the local food environment and the association with death from heart failure.

Patient-related factors and external support are influential in vulnerable patients' medication adherence.

The objective of the trial was to compare letermovir with valganciclovir in preventing CMV disease in adults who received a kidney transplant and who are at high risk for CMV disease.

The Moderna mRNA-1273 vaccine was found to be effective for more than 50% of children aged 6 to 23 months.

SGLT-2 inhibitors, GLP-1 receptor agonists, and a non-steroidal mineralocorticoid receptor are all showing promise in the prevention and management of diabetic kidney disease.

People with anxiety and related disorders were found to have vaccine hesitancy related to concerns regarding adverse effects and efficacy.

News research results in Zambia also find that early intervention in the form of antiretroviral therapies and better nutrition may help close the gap.

Research shows that patients with a severe form of psoriasis have a higher risk of death from cardiovascular disease.

The efficacy of Shingrix was 97% in adults 50 years of age and older and 91% in adults 70 years of age and older over an extended follow-up period.

ASCP 2022 session presenters discuss strategies and tools that can help busy pharmacists stay up to date on current medical literature, guidelines, and media.

Look out for this month's latest news on Rx products.

Prior infection with SARS-CoV-2 decreased the risk of being reinfected with Omicron among unvaccinated and vaccinated individuals.

In a panel, pharmacy technicians across the world discuss the different continuing educations requirements in United States, Portugal, and the United Kingdom.

The test has been available under emergency use authorization (EUA) since March of 2020 and was the first commercial molecular test to receive EUA status.

Understanding the relationship between viral protein activity and rapid gene mutations could help researchers save more lives by creating a more effective flu vaccine.

Researchers conducted a review all 8 herpesviruses and their known treatments and found patients experienced encephalitis or another CNS symptom in almost every strain.

An ASCP 2022 session presenter explains some recent updates on vaccination guidance for the older adult population.

Researchers suggest that winter 2020 to 2021 public health interventions lowered natural immunity in children and put them at greater risk of respiratory infection after restrictions were lifted.

The treatment modulates the number of myosin heads that can enter “on actin” states and lowers the probability of force-producing (systolic) and residual (diastolic) cross-bridge formation.

As a part of the Women in Pharmacy series, Catherine Duggan, FRPharmS, CEO of International Pharmaceutical Federation (FIP), explains her hopes for the pharmacy profession following pharmacists’ pivotal and expanding roles in the pandemic.

In a panel, pharmacy technicians across the world discuss how the role for pharmacy technicians will continue to grow post-pandemic in United States, Portugal, and the United Kingdom.

Tacrine was originally brought to the market in 1993 as an acetylcholinesterase inhibitor to fight the symptoms of Alzheimer disease.

A more comprehensive body of regulations is required to achieve consistency and safety for patients.

However, lack of access and awareness about pre-exposure prophylaxis, medication cost, and underestimating disease risk are all barriers to PrEP.

Many pharmacy professionals feel discouraged, underutilized, and undervalued, but the support staff often saves the day.